|
Real-time Estimate
Cboe BZX
10:30:12 2026-09-22 EDT
|
5-day change | 1st Jan Change | ||
| 4.075 USD | +0.12% |
|
-10.76% | -72.41% |
| 08-13 | Seres Therapeutics Files $300 Million Mixed Shelf | MT |
| 08-05 | Seres Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.12% | -10.76% | -11.91% | -37.80% | -72.41% | -75.15% | -92.14% | -97.08% | -98.48% | 40.46M | |
| +4.98% | +5.73% | +3.13% | +63.51% | +85.30% | +54.45% | +113.83% | +10.21% | - | 74.33B | |
| -2.05% | -1.07% | -1.69% | +6.73% | +18.53% | +34.60% | +77.96% | +215.60% | +5,526.49% | 62.26B | |
| -0.66% | +6.97% | +8.33% | +71.28% | +67.46% | +31.36% | +23.45% | -56.31% | - | 27.72B | |
| -0.45% | +0.44% | -2.85% | +22.16% | -30.79% | -16.95% | +360.27% | +351.64% | +703.01% | 26.42B | |
| +2.65% | +4.05% | -10.82% | +11.55% | +5.68% | +1.91% | -3.85% | -70.34% | - | 24.62B | |
| +0.29% | +5.30% | +7.20% | +36.76% | +11.69% | +24.70% | -10.48% | -19.09% | +97.56% | 20.72B | |
| -2.54% | -3.36% | -17.86% | +20.35% | +171.42% | +149.64% | +324.48% | +1,371.57% | +639.24% | 15.01B | |
| +0.73% | +1.57% | +5.95% | +12.55% | +31.86% | +46.02% | +169.06% | +186.11% | +292.10% | 14.18B | |
| +0.62% | -2.01% | +33.94% | +19.40% | -2.51% | -10.73% | +811.78% | +229.15% | +98.26% | 13.48B | |
| -1.09% | +6.01% | -6.27% | +24.92% | +24.99% | -6.72% | +522.48% | - | - | 15.1B | |
| -0.14% | +0.16% | +2.37% | +2.19% | -10.00% | +19.10% | +241.80% | +566.40% | +4,433.91% | 12.06B | |
| -3.42% | +0.68% | +8.55% | +15.61% | -15.13% | -26.79% | +155.73% | +119.95% | - | 11.66B | |
| +1.48% | -0.36% | -10.42% | -12.77% | +8.69% | +43.13% | +123.13% | +104.08% | +682.11% | 9.39B | |
| +1.03% | -1.32% | -19.60% | -14.96% | +5.04% | +117.58% | +156.00% | +11.13% | +859.22% | 9.72B | |
| +4.67% | +8.42% | +16.42% | +22.23% | +345.71% | +230.52% | +434.85% | -12.80% | - | 8.96B | |
| +0.19% | +0.72% | -3.61% | +14.44% | +29.25% | +78.17% | +13.70% | +129.19% | - | 8.77B | |
| -1.12% | +5.17% | +6.94% | +18.88% | +10.21% | -23.70% | +96.17% | -22.59% | - | 8.73B | |
| -0.24% | +2.00% | -13.01% | -7.53% | +183.18% | +506.74% | +682.21% | -51.37% | -42.20% | 8.11B | |
| +1.85% | +4.90% | +11.88% | +20.86% | +11.12% | +149.33% | +464.27% | - | - | 6.98B | |
| Average | +0.37% | -0.92% | +0.33% | +15.52% | +43.96% | +66.36% | +233.24% | +164.75% | +1,199.20% | 18.91B | |
| Weighted average by Cap. | +0.71% | +1.41% | +0.89% | +27.46% | +45.31% | +50.22% | +185.86% | +156.70% | +2,338.67% |
- Stock Market
- Stocks
- MCRB Stock
- Sector Seres Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
